MarketInOut Stock Screener Log In | Sign Up
 

Apimeds Pharmaceuticals US Inc

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/19/2026 16:00
Apimeds Pharmaceuticals US Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization6.04 mln
Float0.81 mln
Earnings Date08/31/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.08
Debt-free

ROE

-68.68
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Apimeds Pharmaceuticals US Inc. is a United Arab Emirates-based company focused on building and managing bitcoin holdings as a core part of its financial strategy. It operates under the ownership of Inscobee Inc.

Key Fundamentals

EPS-35.98
ROE-68.68
ROIC-39.19
ROA-62.46
EBITDA, mln-39.53
EV / EBITDA-0.42
EV / EBIT-0.42

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.65
Short % of Float3.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.79% 6 / 100   
1 Month -31.08% 1 / 100   
2 Months -67.24% 0 / 100   
6 Months -74.33% 1 / 100   
1 Year -75.2% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us